FR3236M - Médicament ayant notamment des propriétés anesthésiques, contenant comme corps actif un dérivé du 10.11-dihydro-5h-dibenzo [a.d.] cycloheptene. - Google Patents

Médicament ayant notamment des propriétés anesthésiques, contenant comme corps actif un dérivé du 10.11-dihydro-5h-dibenzo [a.d.] cycloheptene.

Info

Publication number
FR3236M
FR3236M FR968229A FR968229A FR3236M FR 3236 M FR3236 M FR 3236M FR 968229 A FR968229 A FR 968229A FR 968229 A FR968229 A FR 968229A FR 3236 M FR3236 M FR 3236M
Authority
FR
France
Prior art keywords
cycloheptene
dibenzo
dihydro
medicament
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR968229A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Application granted granted Critical
Publication of FR3236M publication Critical patent/FR3236M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
FR968229A 1963-03-22 1964-03-21 Médicament ayant notamment des propriétés anesthésiques, contenant comme corps actif un dérivé du 10.11-dihydro-5h-dibenzo [a.d.] cycloheptene. Expired FR3236M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26732463A 1963-03-22 1963-03-22

Publications (1)

Publication Number Publication Date
FR3236M true FR3236M (fr) 1965-04-05

Family

ID=23018306

Family Applications (1)

Application Number Title Priority Date Filing Date
FR968229A Expired FR3236M (fr) 1963-03-22 1964-03-21 Médicament ayant notamment des propriétés anesthésiques, contenant comme corps actif un dérivé du 10.11-dihydro-5h-dibenzo [a.d.] cycloheptene.

Country Status (4)

Country Link
BE (1) BE645500A (fr)
FR (1) FR3236M (fr)
GB (1) GB1041986A (fr)
NL (1) NL6403024A (fr)

Also Published As

Publication number Publication date
BE645500A (fr) 1964-09-21
NL6403024A (fr) 1964-09-23
GB1041986A (en) 1966-09-07

Similar Documents

Publication Publication Date Title
FR3570M (fr) Compositions pharmaceutiques contenant des antibiotiques du type de l'oxytétracycline possédant une stabilité améliorée.
ES352329A1 (es) Un metodo de preparar nuevos eteres de oxima.
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
ES8100883A1 (es) Procedimiento para la produccion de un preparado farmaceuti-co
FR1054081A (fr) Couches anti-halo contenant des amides d'acides gras
BE827659A (fr) Medicament contenant comme constituant actif la sapogenine principale du genre helleport
FR3236M (fr) Médicament ayant notamment des propriétés anesthésiques, contenant comme corps actif un dérivé du 10.11-dihydro-5h-dibenzo [a.d.] cycloheptene.
GB1364407A (en) Thiocarbamic acid derivatives
SE7605232L (sv) 1,3-polyhalogen-2-propyletrar
FR3349M (fr) Médicament ayant notamment des propriétés anthelminthiques, comprenant comme corps actif un dérivé de naphtamidine.
ES361305A1 (es) Un metodo para la inhibicion de la enzima doparmina-3-hi- droxilasa.
FR1286939A (fr) Groupe d'éclaircissage de plants, notamment de betteraves
GB1218648A (en) Improvements in hay rolls
GB1100443A (en) 17ª‡-chloroethynyl-13ª‰-ethylgonenolone
ES377523A1 (es) Un procedimiento para fabricar una sustancia combinada, compuesta de acido germanico y cisteina.
BE626351A (fr) Compositions contenant une 2,6-dichlorobenzamidine comme ingrédient actif
GB1315344A (en) Cyclic compounds and processes for their manufacture
Schoenberg et al. The failure of Freund's adjuvant to affect the survival of mice with transplanted Sarcoma 180
FR1494701A (fr) Nouveaux esters-amides dérivés de l'acide n-heptanoïque, et leur utilisation comme plastifiants
BE616139A (fr) Préparations pharmaceutiques contenant des acides trihydroxamiques
GB1140014A (en) Propanol carbamates
FR2025991A1 (en) Preparation of o-carbamoyl-serine hydroxamide - and 4-amino-3-isoxazolidinone
JPS5718607A (en) Injection preparation
FR2013M (fr) Préparations pharmaceutiques renfermant, comme agent a effet sédatif-hypnotique, des amides d'acides trishalogénométhyl-acétiques.
FR1323949A (fr) Esters d'acides phosphoriques et compositions parasiticides les contenant